People with overweight or obesity often struggle to find treatments that work for them. A recent trial looked at oral sodium butyrate, a substance taken by mouth, to see if it could help with weight loss and blood sugar control. The study involved 46 adults aged 30 to 70 years. Some had type 2 diabetes, while others did not. Participants took either the sodium butyrate or a placebo for 12 weeks.
The results were mixed depending on the group. Adults without diabetes lost significantly more weight when taking the sodium butyrate compared to those taking the placebo. On average, the sodium butyrate group lost 7.0 kilograms versus 3.2 kilograms for the placebo group. However, adults with type 2 diabetes did not show a difference in weight loss between the two groups.
Despite the weight results, the drug did help those with diabetes in other ways. It lowered plasma triglycerides and increased time-in-target-range, a measure of blood sugar stability. The study did not report any serious safety issues or side effects during the short follow-up period. This early research suggests potential benefits for specific groups, though more work is needed to understand the full picture.